Smith KS - Search Results

1

Self-association mediated by the Ras association 1 domain of AF6 activates the oncogenic potential of MLL-AF6.

Liedtke M, Ayton PM, Somervaille TC, Smith KS, Cleary ML. Liedtke M, et al. Among authors: smith ks. Blood. 2010 Jul 8;116(1):63-70. doi: 10.1182/blood-2009-09-243386. Epub 2010 Apr 15. Blood. 2010. PMID: 20395419 Free PMC article.

2

Chimeric oncoprotein E2a-Pbx1 induces apoptosis of hematopoietic cells by a p53-independent mechanism that is suppressed by Bcl-2.

Smith KS, Jacobs Y, Chang CP, Cleary ML. Smith KS, et al. Oncogene. 1997 Jun 19;14(24):2917-26. doi: 10.1038/sj.onc.1201249. Oncogene. 1997. PMID: 9205098

3

Disrupted differentiation and oncogenic transformation of lymphoid progenitors in E2A-HLF transgenic mice.

Smith KS, Rhee JW, Naumovski L, Cleary ML. Smith KS, et al. Mol Cell Biol. 1999 Jun;19(6):4443-51. doi: 10.1128/MCB.19.6.4443. Mol Cell Biol. 1999. PMID: 10330184 Free PMC article.

4

Transformation of bone marrow B-cell progenitors by E2a-Hlf requires coexpression of Bcl-2.

Smith KS, Rhee JW, Cleary ML. Smith KS, et al. Mol Cell Biol. 2002 Nov;22(21):7678-87. doi: 10.1128/MCB.22.21.7678-7688.2002. Mol Cell Biol. 2002. PMID: 12370314 Free PMC article.

5

Bmi-1 regulation of INK4A-ARF is a downstream requirement for transformation of hematopoietic progenitors by E2a-Pbx1.

Smith KS, Chanda SK, Lingbeek M, Ross DT, Botstein D, van Lohuizen M, Cleary ML. Smith KS, et al. Mol Cell. 2003 Aug;12(2):393-400. doi: 10.1016/s1097-2765(03)00277-6. Mol Cell. 2003. PMID: 14536079 Free article.

6

The TALE homeodomain protein Pbx2 is not essential for development and long-term survival.

Selleri L, DiMartino J, van Deursen J, Brendolan A, Sanyal M, Boon E, Capellini T, Smith KS, Rhee J, Pöpperl H, Grosveld G, Cleary ML. Selleri L, et al. Among authors: smith ks. Mol Cell Biol. 2004 Jun;24(12):5324-31. doi: 10.1128/MCB.24.12.5324-5331.2004. Mol Cell Biol. 2004. PMID: 15169896 Free PMC article.

7

The menin tumor suppressor protein is an essential oncogenic cofactor for MLL-associated leukemogenesis.

Yokoyama A, Somervaille TC, Smith KS, Rozenblatt-Rosen O, Meyerson M, Cleary ML. Yokoyama A, et al. Among authors: smith ks. Cell. 2005 Oct 21;123(2):207-18. doi: 10.1016/j.cell.2005.09.025. Cell. 2005. PMID: 16239140 Free article.

8

A novel monoclonal antibody against DOG1 is a sensitive and specific marker for gastrointestinal stromal tumors.

Espinosa I, Lee CH, Kim MK, Rouse BT, Subramanian S, Montgomery K, Varma S, Corless CL, Heinrich MC, Smith KS, Wang Z, Rubin B, Nielsen TO, Seitz RS, Ross DT, West RB, Cleary ML, van de Rijn M. Espinosa I, et al. Among authors: smith ks. Am J Surg Pathol. 2008 Feb;32(2):210-8. doi: 10.1097/PAS.0b013e3181238cec. Am J Surg Pathol. 2008. PMID: 18223323

9

Glycogen synthase kinase 3 in MLL leukaemia maintenance and targeted therapy.

Wang Z, Smith KS, Murphy M, Piloto O, Somervaille TC, Cleary ML. Wang Z, et al. Among authors: smith ks. Nature. 2008 Oct 30;455(7217):1205-9. doi: 10.1038/nature07284. Epub 2008 Sep 17. Nature. 2008. PMID: 18806775 Free PMC article.

10

GSK-3 promotes conditional association of CREB and its coactivators with MEIS1 to facilitate HOX-mediated transcription and oncogenesis.

Wang Z, Iwasaki M, Ficara F, Lin C, Matheny C, Wong SH, Smith KS, Cleary ML. Wang Z, et al. Among authors: smith ks. Cancer Cell. 2010 Jun 15;17(6):597-608. doi: 10.1016/j.ccr.2010.04.024. Cancer Cell. 2010. PMID: 20541704 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

511 results

Search Page

Filters